(EL) EssilorLuxottica S. A. - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000121667

EL: Lenses, Frames, Sunglasses, Equipment, Instruments, Eyewear

EssilorLuxottica stands as a titan in the global eyewear industry, forged through the merger of two legends: Essilor, the pioneer in lens innovation, and Luxottica, the powerhouse behind iconic eyewear brands. This union created an unparalleled entity, dominationg every link in the value chain from lens manufacturing to brand distribution.

The companys arsenal boasts an impressive array of brands, blending luxury and functionality. On one end, you have the likes of Ray-Ban and Oakley, titans in the premium eyewear space. On the other, Essilors Varilux and Crizal lenses showcase cutting-edge technology, addressing diverse vision needs. This strategic diversification ensures a foothold in every market segment, catering to both the fashion-forward and those seeking functional solutions.

EssilorLuxotticas operational prowess is a masterclass in scale and efficiency. They arm opticians and labs with state-of-the-art equipment, streamlining production. Their global reach is unmatched, serving everyone from independent opticians to massive retailers, plus a robust direct-to-consumer play. This dual approach ensures they capture every sales channel, leaving no stone unturned in their market dominance.

Looking at the numbers, their market cap exceeds €121 billion, a testament to their stability and scale. The current P/E ratio of 52.72 reflects high valuations, likely due to growth expectations, while the forward P/E of 34.13 hints at anticipated expansion. The P/S ratio of 4.70 underscores their substantial revenue generation relative to their size.

For investors, EssilorLuxottica presents a compelling case. Their leadership in innovation and extensive distribution networks position them to capitalize on the growing eyewear demand. With a strong balance sheet and global presence, they are a beacon of stability and growth potential in their sector.

Additional Sources for EL Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EL Stock Overview

Market Cap in USD 132,773m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Health Care Equipment
IPO / Inception

EL Stock Ratings

Growth 5y 89.8%
Fundamental 62.4%
Dividend 75.8%
Rel. Strength 19.2
Analysts -
Fair Price Momentum 276.43 EUR
Fair Price DCF 338.16 EUR

EL Dividends

Dividend Yield 12m 3.41%
Yield on Cost 5y 8.06%
Annual Growth 5y 27.99%
Payout Consistency 98.0%

EL Growth Ratios

Growth Correlation 3m 44.6%
Growth Correlation 12m 92.9%
Growth Correlation 5y 92.2%
CAGR 5y 19.95%
CAGR/Max DD 5y 0.68
Sharpe Ratio 12m 0.33
Alpha 19.08
Beta 0.919
Volatility 24.05%
Current Volume 1230k
Average Volume 20d 615.7k
What is the price of EL stocks?
As of April 04, 2025, the stock is trading at EUR 248.30 with a total of 1,230,016 shares traded.
Over the past week, the price has changed by -7.80%, over one month by -13.54%, over three months by +7.86% and over the past year by +20.37%.
Is EssilorLuxottica S. A. a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, EssilorLuxottica S. A. (PA:EL) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.37 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EL as of April 2025 is 276.43. This means that EL is currently undervalued and has a potential upside of +11.33% (Margin of Safety).
Is EL a buy, sell or hold?
EssilorLuxottica S. A. has no consensus analysts rating.
What are the forecast for EL stock price target?
According to ValueRays Forecast Model, EL EssilorLuxottica S. A. will be worth about 305 in April 2026. The stock is currently trading at 248.30. This means that the stock has a potential upside of +22.83%.
Issuer Forecast Upside
Wallstreet Target Price 275.2 10.8%
Analysts Target Price - -
ValueRay Target Price 305 22.8%